{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:39:06Z","timestamp":1781498346073,"version":"3.54.1"},"reference-count":18,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,3,1]]},"abstract":"<jats:p>We studied the impact of donor cytomegalovirus (CMV) serologic status on CMV viremia and disease when prophylactic granulocyte colony-stimulating factor (G-CSF)\u2013mobilized granulocyte transfusions (GTs) were given following allogeneic peripheral blood stem cell (AlloPBSC) transplantation. A cohort of 83 patients who received 2 prophylactic GTs from ABO-compatible stem cell donors following AlloPBSC transplantation was compared with a cohort of 142 patients who did not. AlloPBSC donors were eligible for granulocyte donation irrespective of their CMV serostatus. Recipients received no prophylactic therapy for CMV. Donor CMV serostatus had no impact on CMV viremia and disease in the 2 cohorts. Our data show that in an era of effective surveillance and preemptive therapy for CMV, AlloPBSC recipients can safely receive 2 transfusions of prophylactic G-CSF\u2013mobilized granulocyte components from CMV-seropositive AlloPBSC donors. This knowledge may help expand the donor pool in areas with a high prevalence of CMV in the general population.<\/jats:p>","DOI":"10.1182\/blood-2002-07-2110","type":"journal-article","created":{"date-parts":[[2003,2,12]],"date-time":"2003-02-12T14:59:36Z","timestamp":1045061976000},"page":"2067-2069","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":31,"title":["Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation"],"prefix":"10.1182","volume":"101","author":[{"given":"Ravi","family":"Vij","sequence":"first","affiliation":[{"name":"From the Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St Louis; and Division of Pediatric Hematology Oncology, Washington University School of Medicine, St Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"DiPersio","sequence":"additional","affiliation":[{"name":"From the Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St Louis; and Division of Pediatric Hematology Oncology, Washington University School of Medicine, St Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Venkatraman","sequence":"additional","affiliation":[{"name":"From the Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St Louis; and Division of Pediatric Hematology Oncology, Washington University School of Medicine, St Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Trinkaus","sequence":"additional","affiliation":[{"name":"From the Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St Louis; and Division of Pediatric Hematology Oncology, Washington University School of Medicine, St Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence T.","family":"Goodnough","sequence":"additional","affiliation":[{"name":"From the Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St Louis; and Division of Pediatric Hematology Oncology, Washington University School of Medicine, St Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy A.","family":"Brown","sequence":"additional","affiliation":[{"name":"From the Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St Louis; and Division of Pediatric Hematology Oncology, Washington University School of Medicine, St Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna J.","family":"Khoury","sequence":"additional","affiliation":[{"name":"From the Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St Louis; and Division of Pediatric Hematology Oncology, Washington University School of Medicine, St Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Devine","sequence":"additional","affiliation":[{"name":"From the Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St Louis; and Division of Pediatric Hematology Oncology, Washington University School of Medicine, St Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Oza","sequence":"additional","affiliation":[{"name":"From the Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St Louis; and Division of Pediatric Hematology Oncology, Washington University School of Medicine, St Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Shenoy","sequence":"additional","affiliation":[{"name":"From the Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St Louis; and Division of Pediatric Hematology Oncology, Washington University School of Medicine, St Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Blum","sequence":"additional","affiliation":[{"name":"From the Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St Louis; and Division of Pediatric Hematology Oncology, Washington University School of Medicine, St Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Adkins","sequence":"additional","affiliation":[{"name":"From the Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St Louis; and Division of Pediatric Hematology Oncology, Washington University School of Medicine, St Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111822043919400_B1","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood.V81.7.1883.1883","article-title":"The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis.","volume":"81","author":"Bensinger","year":"1993","journal-title":"Blood."},{"key":"2019111822043919400_B2","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood.V81.7.1675.1675","article-title":"Therapeutic granulocyte transfusions in 1993.","volume":"81","author":"Strauss","year":"1993","journal-title":"Blood."},{"key":"2019111822043919400_B3","first-page":"590a","article-title":"Reduction in antibiotic utilization and in febrile days by transfusion of G-CSF mobilized prophylactic granulocyte components: a randomized study [abstract].","volume":"94","author":"Adkins","year":"1999","journal-title":"Blood."},{"key":"2019111822043919400_B4","first-page":"58a","article-title":"Improved survival in allogeneic peripheral blood stem cell (PBSC) transplant patients who received prophylactic granulocyte transfusions from HLA-matched donors: long term follow-up [abstract].","volume":"98","author":"Blum","year":"2001","journal-title":"Blood."},{"key":"2019111822043919400_B5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/00007890-199511150-00014","article-title":"Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients.","volume":"60","author":"Brytting","year":"1995","journal-title":"Transplantation."},{"key":"2019111822043919400_B6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1386-6532(98)00046-4","article-title":"Discordant detection of human cytomegalovirus DNA from peripheral blood mononuclear cells, granulocytes and plasma: correlation to viremia and HCMV infection.","volume":"11","author":"Hamprecht","year":"1998","journal-title":"J Clin Virol."},{"key":"2019111822043919400_B7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/infdis\/172.2.365","article-title":"Human cytomegalovirus immediate early and late transcripts are expressed in all major leukocyte populations in vivo.","volume":"172","author":"von Laer","year":"1995","journal-title":"J Infect Dis."},{"key":"2019111822043919400_B8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.bmt.1703513","article-title":"Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.","volume":"29","author":"Yakushiji","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"2019111822043919400_B9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/sj.bmt.1703282","article-title":"Extended antigenemia surveillance and late cytomegalovirus infection after allogeneic BMT.","volume":"28","author":"Machado","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"2019111822043919400_B10","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood.V97.11.3676","article-title":"Frequent detection of rising cytomegalovirus antigenemia after allogeneic stem cell transplantation following a regimen containing antithymocyte globulin.","volume":"97","author":"Kanda","year":"2001","journal-title":"Blood."},{"key":"2019111822043919400_B11","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1182\/blood.V99.6.1978","article-title":"Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study.","volume":"99","author":"Junghanss","year":"2002","journal-title":"Blood."},{"key":"2019111822043919400_B12","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V95.7.2240","article-title":"Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation.","volume":"95","author":"Broers","year":"2000","journal-title":"Blood."},{"key":"2019111822043919400_B13"},{"key":"2019111822043919400_B14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-96-2-149","article-title":"The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation.","volume":"96","author":"Hersman","year":"1982","journal-title":"Ann Intern Med."},{"key":"2019111822043919400_B15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-93-5-671","article-title":"Cytomegalovirus infections associated with leukocyte transfusions.","volume":"93","author":"Winston","year":"1980","journal-title":"Ann Intern Med."},{"key":"2019111822043919400_B16","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1182\/blood.V95.11.3605","article-title":"Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation.","volume":"95","author":"Adkins","year":"2000","journal-title":"Blood."},{"key":"2019111822043919400_B17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1182\/blood.V99.1.390","article-title":"Cytomegalovirus infection in cancer patients receiving granulocyte transfusions.","volume":"99","author":"Narvios","year":"2002","journal-title":"Blood."},{"key":"2019111822043919400_B18","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood.V99.9.3483","article-title":"Cytomegalovirus infections in cancer patients receiving granulocyte transfusions.","volume":"99","author":"Nichols","year":"2002","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/5\/2067\/1261624\/h80503002067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/5\/2067\/1261624\/h80503002067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T22:04:48Z","timestamp":1574114688000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/5\/2067\/106609\/Donor-CMV-serostatus-has-no-impact-on-CMV-viremia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,1]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,3,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-07-2110","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3,1]]}}}